Cargando…
Knowledge transfer: what drug information would specialist doctors need to support their clinical practice? Results of a survey and of three focus groups in Italy
BACKGROUND: The wide offer of information on pharmaceuticals does not often fulfill physicians’ needs: problems of relevance, access, quality and applicability are widely recognized, and doctors often rely on their own experience and expert opinions rather than on available evidence. A quali-quantit...
Autores principales: | Formoso, Giulio, Rizzini, Paolo, Bassi, Maurizio, Bonfanti, Paolo, Rizzardini, Giuliano, Campomori, Annalisa, Mosconi, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007811/ https://www.ncbi.nlm.nih.gov/pubmed/27581665 http://dx.doi.org/10.1186/s12911-016-0355-7 |
Ejemplares similares
-
New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: a budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy)
por: Restelli, Umberto, et al.
Publicado: (2015) -
Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy
por: Rizzardini, Giuliano, et al.
Publicado: (2012) -
Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?
por: Rizzardini, Giuliano, et al.
Publicado: (2012) -
Cost-Utility Analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir Administered as First-Line Therapy for the Treatment of HIV Infection in Italy: From Randomised Trial to Real World
por: Foglia, Emanuela, et al.
Publicado: (2013) -
Correction: Cost-Utility Analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir Administered as First-Line Therapy for the Treatment of HIV Infection in Italy: From Randomised Trial to Real World
por: Foglia, Emanuela, et al.
Publicado: (2014)